Antiva Biosciences website screenshot

Antiva Biosciences

Antiva Biosciences is a clinical-stage biopharmaceutical company developing topical therapeutics that target oncogenic human papillomavirus (HPV) infections and the precancerous cervical lesions they cause, aiming to stop cervical cancer before it starts with at-home, non-surgical treatment. Its lead candidate, ABI-2280, is a topical antiviral in Phase 1b/2 clinical development for high-risk cervical HPV infection, and the company frames its work in support of the World Health Organization's global Cervical Cancer Elimination Initiative. Antiva is backed by venture investors including Canaan Partners and GV, and is tracked in the API Evangelist network as a company profile awaiting further enrichment.

Antiva Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Healthcare, and Life Sciences.

Antiva Biosciences’ developer surface includes engineering blog and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsHealthcareLife SciencesOncologyHPVWomen's Health

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/antiva-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Antiva Biosciences Domain Security

TLSv1.2

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: antiva-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/antiva-biosciences.png
name: Antiva Biosciences
description: Antiva Biosciences is a clinical-stage biopharmaceutical company developing topical therapeutics that target
  oncogenic human papillomavirus (HPV) infections and the precancerous cervical lesions they cause, aiming to stop cervical
  cancer before it starts with at-home, non-surgical treatment. Its lead candidate, ABI-2280, is a topical antiviral in Phase
  1b/2 clinical development for high-risk cervical HPV infection, and the company frames its work in support of the World
  Health Organization's global Cervical Cancer Elimination Initiative. Antiva is backed by venture investors including Canaan
  Partners and GV, and is tracked in the API Evangelist network as a company profile awaiting further enrichment.
url: https://raw.githubusercontent.com/api-evangelist/antiva-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Healthcare
- Life Sciences
- Oncology
- HPV
- Women's Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/antiva-biosciences-domain-security.yml
- type: Website
  url: https://antivabio.com
- type: Blog
  url: https://antivabio.com/news-main.php
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence